Dr. Sarah Glover, Professor and Division Director of Digestive Diseases, has been awarded a National Institutes of Health Research Project (R01) Grant to study the innate and adaptive immune responses of the nasal and gingival epithelium in SARS-CoV-2 infection and vaccination.